A clinical trial at Brown University Health to treat chronic low back pain with a one-time, non-surgical injection treatment ...
NEW YORK (Reuters Health) - Physical therapy and steroid injections work equally well for shoulder pain, according to a new study. Researchers compared the treatments for people with shoulder ...
One of the ways scientists hope to offer better treatments for vision loss is through gene therapy, where carefully selected genetic material is injected into the eyes to address mutations.
Dupilumab, a simple pre-filled pen that people inject themselves with every two weeks, is the first biologic that targets both the symptoms of COPD and an underlying cause of the disease. It brings ...
STOCKHOLM — Trial results are demonstrating positive findings for a single intravitreal injection gene therapy for patients with neovascular age-related macular degeneration (nAMD) who previously ...
Montréal, Canada - November 11, 2010 - Theratechnologies (TSX: TH) announced today that the U.S. Food and Drug Administration ("FDA") has approved EGRIFTATM (tesamorelin for injection) as the first ...
The FDA has granted approval to a larger vial size of nelarabine injection (SH-111) for use in treatment of adult and ...
This document sets out CSP expectations for learning and development in injection therapy. Injection therapy is widely ...
What if CAR T cells, revolutionary cancer fighters normally manufactured in the lab, could be created inside the patient? This quest to simplify CAR T therapy has brought two biotech companies to a ...
Please provide your email address to receive an email when new articles are posted on . Older adults with type 1 diabetes may be able to reduce HbA1c and the occurrence of hypoglycemia, diabetic ...
Please provide your email address to receive an email when new articles are posted on . Adults with acromegaly assigned an investigational oral form of the somatostatin analogue octreotide maintained ...
The Indomo ClearPen is yet to be approved in the UK, but the founders hope for future availability ...